Enhanced, Unaltered and Impaired Nitric Oxide-mediated Endothelium-dependent Relaxation in Experimental Diabetes Mellitus: Importance of Disease Duration
Overview
Authors
Affiliations
Long-term diabetes mellitus is characterized by impaired endothelium-dependent relaxation. In contrast, there is limited information on endothelial function in the early stages of the disease. In this study, we evaluated endothelial function ex vivo at early, intermediate and later stages of streptozotocin (STZ)-induced diabetes mellitus. We also evaluated the contribution of various endothelium-derived vasoactive factors at these stages of disease. In aortic rings contracted with norepinephrine, endothelium-dependent relaxation to acetylcholine was increased at 24 h following injection with streptozotocin compared with controls, normal after 1 and 2 weeks of disease or impaired at 8 weeks of disease. Endothelium-independent relaxation to nitroglycerin was unaltered at all stages. The enhanced relaxation at 24 h was mimicked in rings from alloxan-induced diabetic rats. Acute exposure of normal rings to streptozotocin in vitro caused no perturbation in acetylcholine-stimulated relaxation. Enhanced relaxation in diabetic rings at 24 h persisted in the presence of either indomethacin or tetraethylammonium. Acetylcholine-induced relaxation was blocked in both control and diabetic rings using L-nitroarginine but not by aminoguanidine. This suggests that the increased response was mediated by enhanced constitutive nitric oxide (NO). These studies show a triphasic response of increased, unaltered and impaired endothelium-dependent relaxation within the same model but dependent on the duration of disease. These studies could reconcile previous conflicting data in the literature and account for the observations of increases in tissue blood flow seen in early stages of experimental and human diabetes mellitus.
Influence of rutin and its combination with metformin on vascular functions in type 1 diabetes.
David S, Lai P, Chellian J, Chakravarthi S, Rajabalaya R Sci Rep. 2023; 13(1):12423.
PMID: 37528147 PMC: 10394083. DOI: 10.1038/s41598-023-39442-6.
Elmahallawy E, Alsharif K, Alblihd M, Hamad A, Nasreldin N, Alsanie W Front Vet Sci. 2023; 10:1089733.
PMID: 37065258 PMC: 10102477. DOI: 10.3389/fvets.2023.1089733.
Glucose-Related Traits and Risk of Migraine-A Potential Mechanism and Treatment Consideration.
Islam M, Nyholt D Genes (Basel). 2022; 13(5).
PMID: 35627115 PMC: 9141901. DOI: 10.3390/genes13050730.
Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population.
Akhlaghipour I, Bina A, Mogharrabi M, Fanoodi A, Ebrahimian A, Khojasteh Kaffash S Hum Genomics. 2022; 16(1):11.
PMID: 35366956 PMC: 8976361. DOI: 10.1186/s40246-022-00383-2.
Unuvar S, Melekoglu R, Salva E, Acar C, Yasar S J Diabetes Metab Disord. 2021; 19(2):1391-1396.
PMID: 33520842 PMC: 7843814. DOI: 10.1007/s40200-020-00659-1.